Source MDx today announced a partnership with Brigham and Women’s Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers […]
Sequenom, Inc. (NASDAQ: SQNM), a leading provider of molecular diagnostic applications and genetic analysis products and services, today announced that it has licensed from Xenomics, Inc. (XNOM.PK), a developer of noninvasive molecular diagnostic tests, exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed […]
Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that it has licensed to Sequenom, Inc., a genetics and molecular diagnostics company (NASDAQ: SQNM), exclusive rights to Xenomics patents for the development of prenatal research and diagnostic products based on the Company’s proprietary Transrenal DNA/RNA (Tr-DNA/RNA) technology. The agreement provides for an […]
Finnish biotechnology company Mobidiag launches its first CE-marked product for In Vitro Diagnostics (IVD) of sepsis. The microarray-based Prove-it(TM) Sepsis is invincible in both the coverage and the rate of detecting dangerous bacteria including the superbug MRSA from positive blood culture samples in a single test. The test enables simultaneous identification of 50 species in […]
BILTHOVEN and AMSTERDAM, The Netherlands, October 30 — InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announce today the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA’s proprietary library of miRNAs. Under the research collaboration, InteRNA will apply its unique lentiviral-based miRNA overexpression […]
Spartan Bioscience Inc, a Canadian molecular diagnostics company that develops, manufactures, and markets DNA analyzers for on-demand applications, and NorDiag ASA, a Norwegian biotechnology company that develops, manufacturers and markets automated nucleic acid sample preparation instruments and magnetic bead based reagents for assays that require the purification of nucleic acid from difficult clinical samples such […]
FREMONT, Calif., Oct. 29 — Vermillion, Inc. (OTC Bulletin Board: VRML) announced today that it has agreed with Quest Diagnostics to extend the Strategic Alliance Agreement between the parties through October, 2009. This extension will enable the companies to continue work on the development and commercialization of two tests, OVA1(TM) and VASCLIR(TM). The OVA1 test […]
ReaX™ PCR Assays For Effortless Detection of Hospital Acquired Infections Picture available on request from nickim@alto-marketing.com Cardiff, UK, 29 October 2008 – Q Chip Ltd, a leading developer of microencapsulation solutions, has expanded its ReaX™ range of enhanced PCR products by the introduction of ReaX beads for the detection of bacterial and viral hospital acquired […]
Sequenom, Inc. (NASDAQ: SQNM) today announced the launch of an independent, prospective, multi-center observational study to document the performance of Sequenom’s SEQureDx(TM) Trisomy 21 technology for Down syndrome based upon Sequenom’s SEQureDx Technology. The study, RNA-based Noninvasive Aneuploidy (RNA), will be directed by Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine, Brown University Medical […]
SUNNYVALE, Calif., Oct. 27 — Cepheid (Nasdaq: CPHD – News) today noted an announcement from Birmingham Children’s Hospital highlighting results using Cepheid’s Xpert(TM) MRSA test, which runs on the GeneXpert® System, to implement a screening program for all patients being admitted to its Intensive Care Unit (ICU). The Birmingham Children’s Hospital announcement, released yesterday, stated […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
